Amphastar pharmaceuticals inc simplifies management structure

Amphastar pharmaceuticals, inc. announces simplification of management structure.amphastar pharmaceuticals - announces a recent simplification of co's management by removing a layer of management in organizational structure.amphastar pharmaceuticals - jason b. shandell has stepped down as president, general counsel, member of board of directors, effective april 10, 2020.amphastar pharmaceuticals - jack zhang, ceo,chief scientific officer, member of board,assumed role & responsibilities of president, effective april 10.amphastar pharmaceuticals inc - currently has seven andas, filed with fda targeting products with a market size of about $1.9 billion.amphastar pharmaceuticals inc - currently has three biosimilar products in development targeting products with a market size of approximately $13 billion.
AMPH Ratings Summary
AMPH Quant Ranking